Camarda Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Camarda Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-37,387	Closed	-$2.15M	–	289
2014 Q4	$2.15M	Sell	37,387 -5,546	-13%	-$309K	1.37%	25
2014 Q3	$2.31M	Buy	42,933 +1,225	+3%	+$64.9K	1.6%	23
2014 Q2	$2.19M	Sell	41,708 -1,714	-4%	-$87.6K	1.5%	24
2014 Q1	$2.29M	Sell	43,422 -6,044	-12%	-$279K	1.76%	17
2013 Q4	$1.98M	Buy	+49,466	New	+$1.95M	1.62%	31
2013 Q3	–	Sell	-41,329	Closed	-$1.62M	–	226
2013 Q2	$1.62M	Buy	+41,329	New	+$1.61M	1.48%	28

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Camarda Financial Advisors's TEVA Position: Q1 2015 in Review

Camarda Financial Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2015, closing a stake of 37,387 shares — an estimated $2.15M sold.

Camarda Financial Advisors first reported a position in TEVA in Q2 2013 and held it in 6 quarters. The position peaked at $2.31M in Q3 2014. 821 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

Camarda Financial Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Camarda Financial Advisors sold 37,387 Teva Pharmaceuticals shares in Q1 2015, an estimated $2.15M.
Camarda Financial Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Camarda Financial Advisors's Teva Pharmaceuticals position peaked at $2.31M in Q3 2014.
821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on Camarda Financial Advisors's 13F filing for Q1 2015, filed 15 Apr 2015.